Opteev develops biosensor technology that provides early warning systems for COVID-19 and other respiratory viruses, enabling timely detection of health threats. This technology enhances public health safety by facilitating proactive measures against viral outbreaks.
Funding
Funding not disclosed
Founders
Product
Problem
Early detection of highly contagious respiratory viruses like COVID-19 is crucial for preventing widespread outbreaks, but current testing methods often lack the speed and accessibility needed for timely intervention. Traditional lab-based diagnostics can be slow and require specialized equipment, while rapid antigen tests may have limited sensitivity, especially in the early stages of infection or with emerging variants.
Solution
Opteev is developing biosensor technology designed to provide rapid, on-site detection of respiratory viruses, enabling proactive measures against potential outbreaks. Their system aims to offer a faster and more accessible alternative to traditional testing methods, potentially facilitating earlier diagnosis and containment of infectious diseases. The technology is intended to be deployed in various settings, providing real-time monitoring and early warnings of viral threats.
Target Audience
The primary target audience includes public health organizations, healthcare providers, schools, businesses, and other entities seeking to implement proactive measures against viral outbreaks.
Features
- Biosensor technology for rapid detection of respiratory viruses
- Aims to provide early warning systems for COVID-19 and other respiratory illnesses
- Designed for on-site deployment in various settings